Tech Company Financing Transactions

Amira Pharmaceuticals Funding Round

Novo Ventures, Avalon Ventures and Prospect Venture Partners participated in a $25 million Series B capital raise for Amira Pharmaceuticals. This VC investment round was announced on 3/23/2007.

Transaction Overview

Company Name
Amira Pharmaceuticals
Announced On
3/23/2007
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series B
Investors

Novo Ventures (Lead Investor) (Heath Lukatch)

Avalon Ventures (Kevin Kinsella)

Prospect Venture Partners (James Tananbaum)

Versant Ventures (Bradley Bolzon)

Proceeds Purpose
The additional funding will enable the company to advance multiple drug candidates through clinical proof of concept, including AM103 to treat respiratory and cardiovascular conditions. An Investigational Medicinal Product Dossier (IMPD) for AM103 is expected to be filed in Europe within the next two months.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
9535 Waples St. 100
San Diego, CA 92121
USA
Phone
(858) 228-4650
Website
www.amirapharm.com
Email Address
[email protected]
Overview
Amira Pharmaceuticals is a privately-held biopharmaceutical company, focused on leveraging the deep expertise of a team of scientists in the field of inflammatory diseases.
Profile
Amira Pharmaceuticals LinkedIn Company Profile
Social Media
Amira Pharmaceuticals Company Twitter Account
Company News
Amira Pharmaceuticals News
Facebook
Amira Pharmaceuticals on Facebook
YouTube
Amira Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Robert Baltera
  Robert Baltera LinkedIn Profile  Robert Baltera Twitter Account  Robert Baltera News  Robert Baltera on Facebook
Chief Financial Officer
Michael Swanson
  Michael Swanson LinkedIn Profile  Michael Swanson Twitter Account  Michael Swanson News  Michael Swanson on Facebook
Chief Scientific Officer
Peppi Prasit
  Peppi Prasit LinkedIn Profile  Peppi Prasit Twitter Account  Peppi Prasit News  Peppi Prasit on Facebook
Vice President
Isabelle DeArmond
  Isabelle DeArmond LinkedIn Profile  Isabelle DeArmond Twitter Account  Isabelle DeArmond News  Isabelle DeArmond on Facebook
Vice President
Jilly Evans
  Jilly Evans LinkedIn Profile  Jilly Evans Twitter Account  Jilly Evans News  Jilly Evans on Facebook
Vice President
John Hutchinson
  John Hutchinson LinkedIn Profile  John Hutchinson Twitter Account  John Hutchinson News  John Hutchinson on Facebook

 

 

Browse more venture capital transactions:

Prev: 3/23/2007: Endocyte venture capital transaction
Next: 3/23/2007: Epitek venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.